Abstract
Transmyocardial laser revascularization (TMR) has been used to treat patients with end-stage coronary artery disease since the early 1980s. Following several individual and multi-institutional investigations, prospective randomized clinical trials have demonstrated symptomatic relief for patients treated with transmyocardial laser revascularization. Two different types of lasers are being used in the clinical arena, Holmium:YAG and CO2. Additionally, two different methods of laser revascularization have been attempted: open surgical and cathetered-based approaches.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 86-91 |
| Number of pages | 6 |
| Journal | Cardiovascular Reviews and Reports |
| Volume | 24 |
| Issue number | 2 |
| State | Published - Feb 1 2003 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine